Skin cancer decisions — 2022

The Veteran's hypertension is granted as due to herbicide agent exposure. The claims for basal cell carcinoma, hypertension secondary to PTSD, erectile dysfunction secondary to PTSD, and sarcoidosis secondary to asthma/rhinitis are remanded.

The Board has decided to remand the Veteran's claims for skin cancer and pancreatitis due to the need for additional evidentiary development, including obtaining a copy of the National Academies of Sciences, Engineering & Medicine's (NAS) report on Agent Orange exposure.

The Board denied the Veteran's claim for service connection for a skin disorder, including benign nevi and skin cancer, finding that there was no evidence of herbicide exposure during service and insufficient medical opinion to establish a link between current conditions and in-service treatment.

The Board has remanded the case due to insufficient examination regarding the etiology of the Veteran's melanoma and its relation to service-connected chloracne. The examiner is asked to provide a new opinion on whether the Veteran's skin cancer, including melanoma, was caused by in-service exposure to herbicides or if it is secondary to his service-connected chloracne.

The Board has decided to remand the case due to a duty to assist error, and will need to obtain an opinion on whether the Veteran's skin cancer is related to his service, including presumed exposure to Agent Orange.

The Veteran's claim for an earlier effective date of service connection for prostate cancer was granted, with the effective date set at April 30, 2010.

The Board has remanded the claims for ischemic heart disease, pulmonary congestion, skin cancer, and cause of death due to service connection purposes. The issues are related to exposure at Camp Lejeune. Additional medical opinions are needed regarding these conditions.

The Board has granted service connection for the Veteran's residuals of skin cancer, finding that there is at least a reasonable doubt in favor of the claim based on direct exposure to an herbicide agent during active duty.

The Veteran's lung cancer is rated at 100 percent effective April 1, 2014. Service connection for skin cancer, to include as due to herbicide exposure, is denied.

The Veteran's appeal for service connection for peripheral neuropathy of the upper and lower extremities, including as secondary to diabetes mellitus, is dismissed.,The Veteran's appeal for service connection for peripheral neuropathy of the upper and lower extremities, including as secondary to diabetes mellitus, is dismissed.

The Veteran's claim for service connection for a scar on the left lower extremity as a residual of a tibial/shin laceration is granted. The claims for lumbar spine disability, bilateral hearing loss, and skin disabilities are denied.

The Veteran's claims for service connection on multiple conditions have been dismissed due to his death.

The Board has remanded the case due to insufficient evidence regarding the etiology of the Veteran's skin cancer, specifically whether it is related to herbicide exposure during service or sun exposure.

The Board has remanded the cases for further development and to obtain additional medical opinions regarding the Veteran's claims of service connection for right knee osteoarthritis, lymphoma, and skin cancer.

The Veteran's appeal for a disability rating exceeding 10 percent for bilateral hearing loss is dismissed. The Veteran's claim for service connection for skin cancer and residuals thereof, as well as his claim for service connection for a back disability, are granted.

Your appeal has been dismissed due to the Veteran's death before a decision was made.

The Board has remanded the claims for service connection and TDIU due to incomplete development of evidence, including verification of exposure to contaminated wells in Okinawa and Guam.

The Veteran's skin condition, to include dermatitis and eczema, is granted as service connected. The right shoulder disability and left shoulder disability are also granted as service connected.

The Board has remanded the case due to insufficient medical opinions regarding whether the Veteran's skin cancer is related to his service-connected back disability, including Humira medication. The VA needs to obtain a new opinion addressing these issues.

The Veteran's claim for a higher rating for his service-connected bilateral hearing loss was denied as the evidence did not show that his condition warranted a compensable rating.,Service connection for skin cancer was also denied, with the Board finding no evidence to support a link between the Veteran's skin cancers and his military service.